<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab3">
 <label>Table 3</label>
 <caption>
  <p>Morphometric analysis of Leydig cells</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Study Groups
     <sup>a</sup>
    </th>
    <th>Number of Leydig cell nuclei per section</th>
    <th>Median (L 25%; U75%)</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Control (H
     <sub>2</sub>O)
    </td>
    <td>304</td>
    <td>24.22 (20.53, 28.33)</td>
   </tr>
   <tr>
    <td>PADE, 25 mg/kg</td>
    <td>242</td>
    <td>21.18 (17.41, 24.27) **</td>
   </tr>
   <tr>
    <td>PADE, 125 mg/kg</td>
    <td>236</td>
    <td>20.22 (17.41; 23.45) **</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <sup>a</sup> Male rats were treated with either H
   <sub>2</sub>O (control) or PADE (25 or 125 mg/kg) for 60 days before mating; ** 
   <italic>p</italic> &lt; 0.05
  </p>
 </table-wrap-foot>
</table-wrap>
